Literature DB >> 8612602

Association of Lyn tyrosine kinase with the nuclear matrix and cell-cycle-dependent changes in matrix-associated tyrosine kinase activity.

V Radha1, S Nambirajan, G Swarup.   

Abstract

The nuclear matrix isolated from HeLa cells and Rat2 fibroblasts harbors tyrosine kinase and tyrosine phosphatase activities. Polypeptides of 53, 56 and 60 kDa, associated with this subnuclear structure, were phosphorylated at tyrosine in vivo. By immunoblot and immunolabelling experiments, we identified one of the nuclear-matrix-associated tyrosine kinases as Lyn, a Src family member. Lyn was distributed as foci throughout the matrix. The p56 and p53 isoforms of Lyn remained firmly associated with the nuclear matrix after a variety of matrix preparation procedures, and were not detectable in the chromatin fraction of the nucleus. The tyrosine kinase activity associated with the nuclear matrix showed cell-cycle-dependent changes, maximum activity being observed at the G1/S transition phase. Polyoma-virus-transformed rat fibroblast cells showed sixfold higher tyrosine kinase activity in the nuclear matrix preparations compared to that in untransformed cells. These observations are consistent with the suggestion that tyrosine kinase activity associated with the nuclear matrix may be an important determinant of cellular proliferation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8612602     DOI: 10.1111/j.1432-1033.1996.00352.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  15 in total

1.  Src family kinases promote silencing of ATR-Chk1 signaling in termination of DNA damage checkpoint.

Authors:  Yasunori Fukumoto; Mariko Morii; Takahito Miura; Sho Kubota; Kenichi Ishibashi; Takuya Honda; Aya Okamoto; Noritaka Yamaguchi; Atsushi Iwama; Yuji Nakayama; Naoto Yamaguchi
Journal:  J Biol Chem       Date:  2014-03-14       Impact factor: 5.157

2.  Kinase impact assessment in the landscape of fusion genes that retain kinase domains: a pan-cancer study.

Authors:  Pora Kim; Peilin Jia; Zhongming Zhao
Journal:  Brief Bioinform       Date:  2018-05-01       Impact factor: 11.622

3.  Regulation of Yin Yang 1 by Tyrosine Phosphorylation.

Authors:  Gary Z Wang; Stephen P Goff
Journal:  J Biol Chem       Date:  2015-07-21       Impact factor: 5.157

4.  Localization of human cytomegalovirus structural proteins to the nuclear matrix of infected human fibroblasts.

Authors:  V Sanchez; P C Angeletti; J A Engler; W J Britt
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

5.  Tyrosine phosphorylation of nuclear-membrane protein emerin by Src, Abl and other kinases.

Authors:  Kathryn E Tifft; Katherine A Bradbury; Katherine L Wilson
Journal:  J Cell Sci       Date:  2009-09-29       Impact factor: 5.285

6.  The immunopharmacologic potential of Semaxanib and new generation directed therapeutic drugs: Receptor tyrosine kinase regulation with anti-tumorigenensis/angiogenesis properties.

Authors:  John J Haddad
Journal:  Saudi Pharm J       Date:  2011-09-23       Impact factor: 4.330

7.  Lapatinib antagonizes multidrug resistance-associated protein 1-mediated multidrug resistance by inhibiting its transport function.

Authors:  Shao-lin Ma; Ya-peng Hu; Fang Wang; Zhen-cong Huang; Yi-fan Chen; Xiao-kun Wang; Li-wu Fu
Journal:  Mol Med       Date:  2014-09-08       Impact factor: 6.354

8.  Regulation of p73 by Hck through kinase-dependent and independent mechanisms.

Authors:  Preeti Paliwal; Vegesna Radha; Ghanshyam Swarup
Journal:  BMC Mol Biol       Date:  2007-05-30       Impact factor: 2.946

9.  Trafficking of Lyn through the Golgi caveolin involves the charged residues on alphaE and alphaI helices in the kinase domain.

Authors:  Kousuke Kasahara; Yuji Nakayama; Kikuko Ikeda; Yuka Fukushima; Daisuke Matsuda; Shinya Horimoto; Naoto Yamaguchi
Journal:  J Cell Biol       Date:  2004-06-01       Impact factor: 10.539

Review 10.  Thyroid Hormones as Renal Cell Cancer Regulators.

Authors:  Łukasz Szymański; Damian Matak; Ewa Bartnik; Cezary Szczylik; Anna M Czarnecka
Journal:  J Signal Transduct       Date:  2016-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.